Hypophosphatasia: A Novel Mutation Associated with an Atypical Newborn Presentation
PDF

Case Report

Hypophosphatasia: A Novel Mutation Associated with an Atypical Newborn Presentation

J Clin Res Pediatr Endocrinol 2020;12(1):104-108 DOI: 10.4274/jcrpe.galenos.2019.2018.0263
, , , , ,
PDF
Permissions

Abstract

Hypophosphatasia, a rare genetic disease affecting bone metabolism, is characterized by decreased activity of tissue non-specific alkaline phosphatase (TNAP). The gene encoding TNAP (ALPL) has considerable allelic heterogeneity, which could explain different degrees of enzyme activity resulting in a wide clinical variability. We report the case of a preterm newborn in whom a corneal opacity was detected at birth. Blood tests performed to investigate this finding showed low alkaline phosphatase concentrations. The corneal opacity disappeared within a week but alkaline phosphatase remained persistently low. With persistently decreased levels of alkaline phosphatase, upon suspicion of hypophosphatasia, plain radiography detected changes suggestive of rickets. Sequencing of the ALPL gene revealed a heterozygous variant that has not been described in the literature to date. Our patient’s condition may be an atypical neonatal form of the syndrome, with a mild phenotype, very different from the classic neonatal form, which can lead to severe skeletal disease and respiratory failure. However, it could also be an early diagnosis of the childhood form, which is associated with a better prognosis.

Keywords: Hypophosphatasia, mutation, newborn, alkaline phosphatase

Read the full text

2 sections · 2 figures · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Whyte MP. Hypophosphatasia (chapter 22) IN Genetics of Bone Biology and Skeletal Disease. Elsevier, 2013:337-358.

2

Mornet E. Hypophosphatasia. Orphanet J Rare Dis 2007;2:4.

3

Mornet E, Hofmann C, Bloch-Zupan A, Girschick H, Le Merrer M. Clinical utility gene card for: Hypophosphatasia. Eur J Hum Gen 2014:22. Epub 2013 Aug 7

4

Whyte MP. Hypophosphatasia: An overview For 2017. Bone 2017;102:15-25. Epub 2017 Feb 24

5

Whyte MP, Walkenhorst DA, Fedde KN, Henthorn PS, Hill CS. Hypophosphatasia: levels of bone alkaline phosphatase immunoreactivity in serum reflect disease severity. J Clin Endocrinol Metab 1996;81:2142-2148.

6

The Tissue Nonspecific Alkaline Phosphatase Gene Mutation Database. Retrieved from www.sesep.uvsq.fr/03_hypo_mutations.php#mutations; December 30, 2018.

7

Lessell S, Norton EW. Band Keratopathy and Conjunctival Calcification in Hypophosphatasia. Arch Ophthalmol 1964;71:497-499.

8

Zurutuza L, Muller F, GibratJF, Taillandier A, Simon-Bouy B, SerreJL, Mornet E. Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet 1999;8:1039-1046.

9

Brun-Heath I, Lia-Baldini A, Maillard S, Taillandier A, Utsch B, Nunes ME, Serre JL, Mornet E. Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia. Eur J Med Genet 2007;50:367-378. Epub 2007 Jul 21

10

Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-1081. Epub 2009 Jun 25

11

Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013.

12

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424. Epub 2015 Mar 5

13

Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C. Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia. J Clin Endocrinol Metab 2016;101:334-342. Epub 2015 Nov 3